Clinical trial · Observational
Outcome of GI Cancer in NCKUH
Explore the Diagnosis and Treatment Outcome of Alimentary Tract Cancer in National Cheng Kung University Hospital
NCT05700188CI-TRIAL-00063438completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Alimentary tract cancer patients treated at National Cheng Kung University Hospital during 2013/01/01 to 2020/12/31 were reviewed.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Collection of Real-world Data in a Single Institute | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (4)
- label
- Resectable
- description
- Patients with resectable pancreatic cancer
- label
- Borderline resectable
- description
- Patients with borderline resectable pancreatic cancer
- label
- Locally advanced
- description
- Patients with locally advanced unresectable pancreatic cancer
- label
- Metastatic
- description
- Patients with metastatic pancreatic cancer
Primary outcomes (1)
- measure
- Overall survival (OS)
- timeFrame
- 10 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
Show eligibility criteria text
Inclusion Criteria: All patients with pancreatic cancer treated at National Cheng Kung University Hospital during 2013/01/01 to 2020/12/31 Exclusion Criteria: No treatment or refuse treatment
References
Publications (1)
- DERIVEDSu YY, Chao YJ, Wang CJ, Liao TK, Su PJ, Huang CJ, Chiang NJ, Yu YT, Tsai HM, Chen LT, Shan YS. The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer: a cross sectional study. Int J Surg. 2023 Sep 1;109(9):2614-2623. doi: 10.1097/JS9.0000000000000495. PMID 37300888